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Abstract
Aims/hypothesis Approximately 25% of people with type 1 diabetes have suppressed counterregulatory hormonal and symp-
tomatic responses to insulin-induced hypoglycaemia, which renders them at increased risk of severe, disabling hypoglycaemia.
This is called impaired awareness of hypoglycaemia (IAH), the cause of which is unknown. We recently proposed that IAH
develops through habituation, a form of adaptive memory to preceding hypoglycaemia. Consistent with this hypothesis, we
demonstrated restoration of defective counterregulatory hormonal responses to hypoglycaemia (referred to as dishabituation) in a
rodent model of IAH following introduction of a novel stress stimulus (high intensity training [HIT]). In this proof-of-concept
study we sought to further test this hypothesis by examining whether a single episode of HIT would amplify counterregulatory
responses to subsequent hypoglycaemia in people with type 1 diabetes who had IAH (assessed by Gold score ≥4, modified
Clarke score ≥4 or Dose Adjustment For Normal Eating (DAFNE) hypoglycaemia awareness rating 2 or 3). The primary
outcome was the difference in adrenaline response to hypoglycaemia following both a single episode of HIT and rest.
Methods In this randomised, crossover study 12 participants aged between 18 and 55 years with type 1 diabetes for ≥5 years and
an HbA1c <75 mmol/mol (9%) were recruited. Individuals were randomised using computer generated block randomisation to
start with one episode of HIT (4 × 30 s cycle sprints [2 min recovery] at 150% of maximum wattage achieved during V˙O2peak
assessment) or rest (control). The following day they underwent a 90 min hyperinsulinaemic–hypoglycaemic clamp study at
2.5 mmol/l with measurement of hormonal counterregulatory response, symptom scores and cognitive testing (four-choice
reaction time and digit symbol substitution test). Each intervention and subsequent clamp study was separated by at least 2 weeks.
The participants and investigators were not blinded to the intervention or measurements during the study. The investigators were
blinded to the primary outcome and blood analysis results.
Results All participants (six male and six female, age 19–54 years, median [IQR] duration of type 1 diabetes 24.5 [17.3–29.0]
years, mean [SEM] HbA1c 56 [3.67] mmol/mol; 7.3% [0.34%]) completed the study (both interventions and two clamps). In
comparison with the rest study, a single episode of HIT led to a 29% increase in the adrenaline (epinephrine) response (mean
[SEM]) (2286.5 [343.1] vs 2953.8 [384.9] pmol/l); a significant increase in total symptom scores (Edinburgh Hypoglycaemia
Symptom Scale: 24.25 [2.960 vs 27.5 [3.9]; p<0.05), and a significant prolongation of four-choice reaction time (591.8 [22.5] vs
659.9 [39.86] ms; p<0.01] during equivalent hypoglycaemia induced the following day.
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Conclusions/interpretation These findings are consistent with the hypothesis that IAH develops in people with type 1 diabetes as
a habituated response and that introduction of a novel stressor can restore, at least partially, the adapted counterregulatory
hormonal, symptomatic and cognitive responses to hypoglycaemia.
Trial registration ISRCTN15236211.
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Abbreviations
4CRT Four-choice reaction time
CGM Continuous glucose monitor
DAFNE Dose Adjustment For Normal Eating
DSST Digit symbol substitution test
EHS Edinburgh Hypoglycaemia Symptom Scale
HAAF Hypoglycaemia-associated autonomic failure
HIT High intensity training
IAH Impaired awareness of hypoglycaemia
Introduction
Severe hypoglycaemia is an adverse effect of insulin therapy in
diabetes that has a well-recognisedmorbidity andmortality [1].
Fear of hypoglycaemia often outweighs concerns about long-
term consequences of chronic hyperglycaemia [2], and acts as
a barrier to patients achieving optimal glycaemic control [3].
The major risk factor for severe hypoglycaemia is impaired
awareness of hypoglycaemia (IAH), which increases the risk
of an event six-fold [4]. People with IAH have a reduced
ability to perceive the onset of acute hypoglycaemia [5]. It
affects 25% of all people with type 1 diabetes and, of concern,
the incidence of IAH has not changed in the last 2–3 decades
despite the introduction of insulin analogues and improved
insulin delivery systems [6]. IAH is an acquired abnormality
that should be placed alongside chronic microvascular compli-
cations such as retinopathy, neuropathy and nephropathy as it
can be just as serious and disabling.
The average individual with type 1 diabetes will experience
about two episodes of symptomatic hypoglycaemia per week
[7, 8]. Ordinarily, hypoglycaemia initiates a biological
counterregulatory response that comprises a broad range of
physiological, symptomatic and behavioural changes that
together act to restore normal glucose homeostasis. Failure of
this biological response leads to progressive hypoglycaemia
and may result in individuals being unable to self-treat or to
loss of consciousness (severe hypoglycaemia). In their seminal
study in 1991, Heller and Cryer demonstrated that prior expo-
sure to hypoglycaemia leads to suppression of both hormonal
and symptomatic responses during hypoglycaemia of the same
depth and duration induced the following day [9]. This finding
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was later confirmed in people with type 1 diabetes [10], and it
was further established that increasing the frequency [11] and
duration [12] of prior exposure to hypoglycaemia increases the
extent of counterregulatory response suppression, while strict
avoidance of hypoglycaemia restores counterregulatory
responses [13]. Cumulatively, this exposure to recurrent
hypoglycaemia leads to the development of IAH where indi-
viduals demonstrate a reduced magnitude and increased
threshold (lower glucose) for sympathoadrenal activation and
symptomatic experience of hypoglycaemia. Unfortunately,
despite nearly three decades since Heller’s and Cryer’s seminal
work, the biological mechanisms underpinning the develop-
ment of IAH remain unknown.
Habituation is a form of adaptive memory that develops in
many organisms in response to a repeated, often stressful stim-
ulus [14]. Habituation has been defined as a reduction in the
psychological, behavioural or physiological response to a
stimulus as a result of recurrent or prolonged exposure [14,
15]. Individuals with type 1 diabetes who develop IAH
demonstrate reduced physiological (hormonal and symptom-
atic), psychological (reduced anxiety) and behavioural (inap-
propriate responses to hypoglycaemia while driving)
responses to hypoglycaemia [14–18]. This led us to propose
that IAH may represent a habituated response to repeated
hypoglycaemia. To test this hypothesis, we recently examined
in a rodent model whether IAH could be reversed, at least
temporarily, by the introduction of a single novel stress stim-
ulus, a phenomenon referred to as dishabituation. Rodents
were exposed to non-severe hypoglycaemia three times a
week for a period of 4 weeks (habituation), and subsequently
randomised to a single burst of high intensity training (HIT;
dishabituation) or control (no exercise) before undergoing a
controlled experimental hypoglycaemia study 24 h later [19].
In comparison with control animals, those who had been
exposed to the dishabituatory stimulus had a significantly
greater counterregulatory hormonal response during the
controlled hypoglycaemia study [19]. While this finding
supported the hypothesis that IAH develops as a result of
habituation, the rodents did not have type 1 diabetes and the
counterregulatory response was assessed via hormonal
measures only [19]. In the current proof-of-concept study,
we sought to further test the habituation hypothesis by exam-
ining whether a single burst of HIT would act as a
dishabituatory stimulus in people with long-duration type 1
diabetes who had IAH.
Methods
This was a single-centre, randomised crossover study carried
out at Ninewells Hospital, Dundee, Scotland. Ethics approval
was obtained from an independent research ethics committee
(17/SS/0150) and the study was registered with the
International Standard Randomised Controlled Trials Register
(ISRCTN15236211). The study was conducted in accordance
with the Declaration of Helsinki, and written informed consent
was obtained from all participants before inclusion in the study.
Inclusion criteria were: diagnosis of type 1 diabetes for
at least 5 years, treatment with multiple daily injections
or continuous subcutaneous insulin infusion, HbA1c
<75 mmol/mol (9%), age of 18 to 55 years, and IAH (Gold
score [4] ≥4, modified Clarke score [20] ≥4 or Dose
Adjustment For Normal Eating [DAFNE] hypoglycaemia
awareness rating [21] 2 or 3). Exclusion criteria were: history
of significant cardiac, renal, respiratory or neurological
disease, pregnancy or breastfeeding, treatment with beta-
blockers, history of high-risk foot disease, competitive sports-
man [22] or participation in HIT in the preceding 6 months, or
physical disability that might limit exercise.
The randomisation relates to the order that the HIT or rest
intervention was carried out by the participant. Randomisation
was carried out in a good clinical practice (GCP)-compliant
manner using http://www.randomization.com/.
Participants were identified using the Scottish Diabetes
Research Network (SDRN) and from the diabetes outpatient
clinics in NHS Tayside, Scotland. The study took place at the
Clinical Research Centre, Ninewells Hospital and Medical
School, Dundee.
After obtaining informedwritten consent and initial screen-
ing, which included confirmation of IAH, each participant
attended the Clinical Research Centre on seven separate occa-
sions (See Fig. 1). During visit 1 anthropometric measure-
ments, physical examination and electrocardiogram were
performed. In addition, participants undertook an incremental
maximal to volitional exhaustion exercise test using on a cycle
ergometer (Corival, Lode, Groningen, the Netherlands;
Metamax 3B, CORTEX Biophysik, Leipzig, Germany) to
determine their V˙O2 and peak heart rate.
For this study we have defined HITas episodic short bursts
of high intensity exercise separated by short periods of recov-
ery at lower intensity [23]. The HIT programme used in this
study was 20min in duration; 5 min of gentle warm up cycling
at 50 W, 40–60 rev/min followed by 4 × 30 s cycle sprints
[2 min recovery] at 150% of maximum wattage achieved
during V˙O2peak assessment with an aim to achieve ≥90% peak
heart rate; concluding with 5 min cool down at 50 W, 40–
60 rev/min. Standardised advice [24] was given regarding
blood glucose levels and insulin dose adjustment prior to
and following HIT. The control intervention was 20 min of
seated rest. Venous blood samples were taken for
counterregulatory hormones (adrenaline, noradrenaline
[norepinephrine], glucagon and lactate) at baseline of both
the rest and HIT intervention visits with samples also taken
after the third and fourth bouts of exercise during the HIT
intervention. Each participant underwent a single HIT
programme or controlled rest intervention the afternoon
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before undergoing a hyperinsulinaemic–hypoglycaemic
clamp study the following day. The hyperinsulinaemic–
hypoglycaemic clamp study was used to assess their hormonal
counterregulatory response, symptom awareness and cogni-
tive response. Hyperinsulinaemic–hypoglycaemic clamp
study is considered the gold standard for comparing
counterregulatory response to equivalent hypoglycaemia
[25]. There was a 2 week cooling off period between the
interventions to avoid any lasting effect prior to crossing in
to the second arm of the study.
Experimental hypoglycaemia For each of the two clamp study
visits (separated by at least 2 weeks) participants initially
attended to be fitted with a real-time continuous glucose moni-
tor (CGM) (Dexcom G4, Dexcom, San Diego, CA, USA),
with low glucose alarm (set at 4.0 mmol/l), at least 48 h before
the study, to ensure absence of significant hypoglycaemia
(<3 mmol/l for >20 min) [26] before the clamp procedure.
The evening preceding the clamp study, participants were
advised to reduce their night-time basal insulin by ≈20% and
fast for at least 8 h before coming to the Clinical Research
Visit 1: 3 h
This involved assessment of fitness, physical
examination and familiarisation with HIT programme
Visit 2: 15 min
Visit 3: 1.5 h
Intervention 1
Visit 4: 5 h
Cooling off period: 2 week break
Crossover
Visit 5: 15 min
Visit 6: 1.5 h
Intervention 2
Visit 7: 5 h
Initial assessment
Fit CGM Fit CGM
Fit CGMFit CGM
HIT
Rest
Rest
HIT
Hypoglycaemic 
clamp study
Hypoglycaemic 
clamp study
Fig. 1 Study flow diagram
showing the different stages of the
study
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centre at 08:00 hours. On the morning of the clamp, a retro-
grade cannula was inserted into a dorsal vein of the non-
dominant hand. It was then placed in a heated box at 55–
60°C to arterialise venous blood. This line was used for blood
sampling during the clamp study. In the contralateral arm, the
antecubital vein was cannulated and used for insulin and
dextrose infusions.
Prior to commencing the hypoglycaemic clamp, CGM
data were analysed to ensure there was no hypoglycaemia in
the preceding 24 h. If there was evidence of hypoglycaemia
the study was postponed and the intervention visit repeated.
The study was postponed and intervention repeated three
times in total by two participants: one participant had to repeat
both interventions and one had to repeat the rest intervention
alone.
The insulin infusion (0.3 U/ml) was started at a rate of
50 ml/h for priming purposes until the blood glucose
dropped to below 7 mmol/l into the euglycaemic range,
after which a rate of 1.5 mU−1 kg−1 min−1 was maintained
for the duration of the clamp. 20% dextrose was simulta-
neously infused at a variable rate (Infusomat Space, B.
Braun Medical, Sheffield, UK) based on frequent (every
5 min) bedside plasma glucose measurements (Biosen C-
Line GP+, EKF diagnostics, Cardiff, UK) to maintain
blood glucose at pre-determined levels. Euglycaemia
(glucose 4–6 mmol/l) was achieved and maintained for
the first 30 min of the glucose clamp study, and subse-
quently, blood glucose was reduced over 30 min to a final
glucose level of 2.5 mmol/l. Blood glucose was maintained
at 2.5 mmol/l for 60 min before glucose levels were
returned to the euglycaemic range.
Counterregulatory hormones Arterialised blood for insulin
and counterregulatory hormones (adrenaline, noradrenaline,
glucagon and lactate) was taken every 30 min (t = −30, 0,
30, 60 and 90 min) during the clamp.
Symptoms At each 30 min time point, participants completed
a validated questionnaire, the Edinburgh Hypoglycaemia
Symptom Scale (EHS) [27], scoring 11 symptoms from 1
(not at all) to 7 (very severe) on a visual analogue scale.
Cognitive function tests A series of psychometric tests
recognised to be sensitive to hypoglycaemia were carried
out in the same order, starting approximately 2 min before
each 30 min time point: digit symbol substitution test
(DSST) [28] and four-choice reaction time (4CRT) [29].
Laboratory assays Arterialised blood samples were taken
every 5 min during the clamp and centrifuged, and plasma
glucose was analysed at the bedside by an enzymatic–
amperometric method using chip-sensor technology (Biosen
C-Line GP+). Samples taken at 30 min intervals were
centrifuged within 1 h to separate the serum or plasma and
stored at −80°C before assay. Hormone levels of insulin
(Alpco, Salem, NH, USA; CV inter 4.9%, intra 7.2%), adren-
aline (Alpco; CV inter 19.6%, intra 14.3%), noradrenaline
(Alpco; CV inter 16.3%, intra 12.0%), glucagon (EMD
Millipore, Billerica, MA, USA; CV inter 9.8%, intra 6.52%)
and lactate (Siemens Advia 2100, Siemens Healthcare
Diagnostics, Tarrytown, NY, USA) were measured, and
samples were analysed in duplicate according to the manufac-
turer’s instructions.
Data and statistical analysis The predefined primary endpoint
was the difference in adrenaline response at a glucose level of
2.5 mmol/l following rest and HIT. Power calculations were
based on a previous hypoglycaemic clamp study performed in
a similar cohort of participants with type 1 diabetes and IAH
conducted in our laboratory [30]. For a matched analysis, ten
participants were required to detect a difference of 1 SD with
α set at 0.05 and 80% power. Twelve participants were recruit-
ed to allow for any participants who did not complete both
experimental studies. Secondary outcomes examined were:
difference in symptom awareness score, cognitive function
and other counterregulatory hormone responses during
hypoglycaemia (2.5 mmol/l) following rest and HIT interven-
tion. For the primary and secondary endpoints, a generalised
estimated equation was used adjusting for order effect and
baseline as covariates. A p value <0.05 was considered statis-
tically significant. Paired t tests were used to assess hormonal
and heart rate response to HIT. All data are presented as mean
± SEM. Statistical analyses were conducted using IBM SPSS
Statistics 22 software, IBM, Armonk, NY, USA.
Results
Participant characteristicsRecruitment ran from January 2018
to August 2018. Of the 18 participants screened, five did not
meet the inclusion criteria and one was withdrawn; 12 partic-
ipants gave informed written consent and were randomised
(see Fig. 2). The 12 participants (six male and six female, aged
19–54 years) who completed the study had long-duration type
1 diabetes (median [IQR] duration of type 1 diabetes 24.5
[17.3–29.0] years] and IAH defined by at least one of a
Gold score ≥4 (7/12 participants), modified Clarke] score ≥4
(10/12 participants) or DAFNE hypoglycaemia awareness
rating 2 or 3 (11/12 participants) (electronic supplementary
material [ESM] Table 1). Mean (SEM) HbA1c at
randomisation was 56 (3.67) mmol/mol; 7.3% (0.34).
Physiological response to HIT in type 1 diabetes with IAH All
participants were able to complete the HIT intervention which
involved 4 × 30 s cycle sprints (2 min recovery) at 150% of
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maximum wattage achieved during V˙O2peak assessment. Each
participant achieved their target >90% peak heart rate (Fig.
3a). The HIT programme provided an intense stimulus to
adrenaline (mean [SEM] 228.45 [54.65] vs 1236.83 [203.42]
pmol/l; rest vs HIT, p<0.001] (Fig. 3b) and noradrenaline
(4.77 [0.55] vs 20.42 [2.28] pmol/l; p<0.001] (Fig. 3c), and
resulted in a marked 12-fold increase in lactate (0.95 [0.09] vs
12.28 [0.78] mmol/l; p<0.001) (Fig. 3d).
Dishabituation with HIT in type 1 diabetes with IAH The day
following HIT or rest interventions, participants underwent a
hyperinsulinaemic–hypoglycaemic clamp to assess their
counterregulatory response. During the clamp, plasma
glucose profiles were well matched (Fig. 4a) at baseline (mean
[SEM] 4.81 [0.06] vs 4.80 [0.07] mmol/l [rest vs HIT]) and at
steady state hypoglycaemia (30–90 min) (2.65 [0.06] vs 2.54
[0.06] mmol/l; p = 0.23). Mean glucose infusion rates (30-
90 min) were lower following HIT (2.80 [0.10] vs 3.07
[0.12]), but this difference was not significant; p = 0.23 (Fig.
4b). Plasma insulin was maintained at 704.1 (17.2) vs 655.3
(17.2) pmol/l throughout the clamp period (p = 0.30).
Hormonal counterregulatory response The single HIT inter-
vention had an overall significant effect on the adrenaline
response to subsequent hypoglycaemia. Mean (SEM)
90 min hypoglycaemia-induced adrenaline following rest
and HIT interventions, respectively, was 2286.5 (343.1) vs
2953.8 (384.9) pmol/l; p<0.05 (Fig. 5a). A smaller, non-
significant rise in noradrenaline (5308.3 [656.5] vs 5754.8
[771.2] pmol/l) also followed HIT (p = 0.196). Interestingly,
although not of statistical significance, there was a small
increase in glucagon during equivalent hypoglycaemia
following HIT (48.7 [6.7] vs 57.1 [9.1] ng/l; p = 0.238;
Fig. 5b).
♦
♦
♦
♦
♦
♦
♦♦
♦
♦
♦
♦
Assessed for eligibility (n=18)
Excluded (n=6)
Not meeting inclusion criteria (n=5)
Declined to participate (n=0)
Other reasons (n=1)
Analysed (n=12) 
Excluded from analysis (n=0)
Cross over intervention (rest) (n=6)
Received allocated intervention (n=6)
Did not receive allocated intervention (n=0)
Cross over intervention (HIT) (n=6)
Received allocated intervention (n=6)
Did not receive allocated intervention (n=0)
Allocated to intervention (rest) (n=6)
Received allocated intervention (n=6)
Did not receive allocated intervention (n=0)
Crossover
Randomised (n=12)
Enrolment
Analysis
Allocated to intervention (HIT) (n=6)
Received allocated intervention (n=6)
Did not receive allocated intervention (n=0)
Allocation
Fig. 2 Consort diagram showing participant allocation at each stage of the study
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Symptomatic response Following HIT total symptom scores
(where the minimal possible score is 11) measured during
subsequent hypoglycaemia were significantly increased
(Mean [SEM] EHS score: 24.25 [2.96] vs 27.5 [3.9], respec-
tively, rest vs HIT, p<0.05; Fig. 5c). However, of the EHS
subcategories, while there was a numerically greater autonom-
ic symptom score (11.75 [1.50] vs 12.83 [1.74], rest vs HIT,
respectively, p = 0.144] and neuroglycopenic symptom score
(9.75 [1.46] vs 11.42 [2.11], respectively, p = 0.174) in
response to hypoglycaemia, these did not achieve
significance.
Cognitive response We found that the 4CRT during
hypoglycaemia was significantly prolonged following HIT
(mean [SEM] 591.8 [22.5] vs 659.9 [39.9] ms; rest vs HIT,
respectively, p<0.01; Fig. 5d). There was no difference in the
DSST during hypoglycaemia following rest or HIT.
Discussion
Habituation is a form of adaptive learning where the response
to a stimulus is reduced or ceases altogether following repeat-
ed exposure to the stimulus. This is often considered in the
context of innate behaviours [14, 15]. The gill-withdrawal
(sensory–motor) reflex in Aplysia [31] is a classic model of
habituation. When the gill-withdrawal reflex is repeatedly
induced by a tactile external stimulus to the siphon, the scale
of the response is markedly diminished (habituation).
Hypoglycaemia can be considered an internal sensory stimu-
lus, which leads in turn to a reflex counterregulatory (motor)
response [32]. If organisms adapt to repeated hypoglycaemia
through habituation then it would be predicted that repeated
exposure to hypoglycaemia would lead to a markedly dimin-
ished response. This is indeed the case as has been shown in
humans [9, 10] and rodents [33], and as with a habituated
Fig. 3 Physiological responses to
HIT for each participant. (a) Heart
rate during rest, at the 90%
maximum heart rate target
determined from the V˙O2peak
test, and the maximum heart rate
reached during HIT. (b, c, d)
Adrenaline (b), noradrenaline (c)
and lactate (d) during rest and
HIT interventions. n = 12; values
are the mean ± SEM. ***p<
0.001 by paired t test comparing
rest with HITor max HR reached.
HR, heart rate; max, maximum
Fig. 4 Hyperinsulinaemic–
hypoglycaemic clamp profiles
following HIT and rest (control).
(a) Plasma glucose level. (b)
Glucose infusion rate. n = 12;
values are the mean ± SEM. GIR,
glucose infusion rate
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response, we see widespread and progressive suppression of
physiological (e.g. suppressed counterregulatory hormonal
and symptomatic responses), behavioural (e.g. reduced drive
to feed, impairment when driving [17]) and psychological
(e.g. reduced anxiety) responses to hypoglycaemia as a result
of repeated exposure [16]. Furthermore, a cardinal feature of
the habituated gill-withdrawal reflex in Aplysia is that it can
then be restored, at least temporarily, by applying a strong
tactile stimulus to another part of the animal (dishabituation)
[31]. Our present findings, supported by our previous work in
rodents [19], that hormonal, symptom and cognitive responses
to hypoglycaemia can be at least partially restored following a
single episode of HIT in individuals with long-standing type 1
diabetes who have been exposed to multiple episodes of
hypoglycaemia, therefore provides robust support for the
hypothesis that IAH develops through habituation to recurrent
hypoglycaemia.
There are nine proposed criteria that define habituation [15].
As described, criterion 1: ‘Given that a particular stimulus elicits
a response, repeated applications of that stimulus result in a
decreased response (habituation)’ [15], is characteristic of recur-
rent hypoglycaemia [9, 10]. Similarly, criterion 2: ‘If the stimu-
lus is withheld, the response tends to recover over time (sponta-
neous recovery)’ [15], and we know that hypoglycaemia avoid-
ance can lead to recovery of counterregulatory responses to
subsequent hypoglycaemia [13, 34]. In this study, we have
addressed criterion 8: ‘Presentation of another (usually strong)
stimulus results in recovery of the habituated response
(dishabituation)’, and have shown that it is possible, at least
temporarily, to recover hypoglycaemia counterregulation.
Interestingly, criterion 7: ‘Habituation of response to a given
stimulus exhibits stimulus generalization to other stimuli’, may
explain why our results differ from previous work suggesting
that exercise can further suppress counterregulatory responses to
hypoglycaemia [35, 36]. It is possible that the mild–moderate
exercise regimen, leads through stimulus ‘generalisation’, to
suppression of the subsequent counterregulatory response to
insulin-induced hypoglycaemia. The key differentiating feature
between the studies being the intensity of the different stimulus.
Habituation is considered an adaptive survival response to
repeated exposure of a physiological stressor in order to devel-
op a degree of tolerance of that specific stressor. In contrast,
the physiological response to repeated hypoglycaemia is
currently considered maladaptive and is often referred to as
hypoglycaemia-associated autonomic failure (HAAF), as
originally proposed by Cryer [37]. The termHAAF is, howev-
er, misleading because, as mentioned, the suppressed
counterregulatory response can be reversed in many people
through strict avoidance of hypoglycaemia [13, 34]. This
means the autonomic system does not ‘fail’, and instead is
more likely to be adapting to the presence or absence of
repeated hypoglycaemia. Pre-clinical studies are supportive
of the habituation hypothesis in that recurrent hypoglycaemia
triggers a series of changes at a cellular level that act to induce
tolerance, facilitating organisms to cope better when subse-
quently deprived of energy. For example, prior recurrent
hypoglycaemia protects against neuronal death during subse-
quent very severe hypoglycaemia [38]. Glucocorticoids [39]
and urocortin [40], which are key to neuroprotection and initi-
ation of adaptive cellular mechanisms [41], are also integral to
Fig. 5 Acute exposure to HIT
improves defective
counterregulatory response.
Plasma adrenaline (a), glucagon
(b), total EHS score (c) and 4CRT
(d) during the hyperinsulinaemic–
hypoglycaemic clamp study. n =
12; values are the mean ± SEM.
*p<0.05, **p<0.01 using the
generalised estimate equation
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the organism’s response to recurrent hypoglycaemia.
Therefore, these systematic and cellular responses to recurrent
hypoglycaemia also point to IAH developing as an adaptive,
habituated response to repeated hypoglycaemic stress.
In the current study we employed HIT as the novel
dishabituating stimulus. We confirmed the effectiveness of
the HIT intervention as a novel stimulus by demonstrating that
it evoked a marked rise in heart rate, adrenaline and lactate.
The day following the HIT (or rest) intervention, participants
underwent a controlled hypoglycaemia study where we
demonstrated significant increases induced by preceding
HIT in the hormonal counterregulatory response. There was
also, and of relevance in clinical practice, an increase in total
symptom scores (EHS [27]) in response to matched
hypoglycaemia following HIT, indicating participants were
more aware of hypoglycaemia. Finally, the 4CRT was
prolonged during hypoglycaemia following HIT. Choice reac-
tion time is used to examine psychomotor and attentional
focus. Acute hypoglycaemia markedly impairs performance
in almost all aspects of executive function in adults with type 1
diabetes, with time taken to complete cognitive testing taking
considerably longer [42, 43]. Zammitt et al have shown that
4CRT is also prolonged during experimental hypoglycaemia
in people with type 1 diabetes and intact awareness, but not in
those with IAH [44]. Our finding of a significant slowing of
4CRT during hypoglycaemia in participants with IAH follow-
ing HIT is therefore indicative that dishabituation has, at least
partially, restored counterregulatory hormonal, symptom and
cognitive responses towards that seen in individuals with
intact awareness.
There are a number of limitations to our study. Although
the hyperinsulinaemic–hypoglycaemic clamp is the gold stan-
dard technique for assessing counterregulatory responses to
hypoglycaemia [25], the studies are conducted under strictly
controlled conditions in a laboratory and, as such, the experi-
ence of hypoglycaemia may not fully reflect its real-world
experience. We also used three different hypoglycaemia
awareness questionnaires [4, 20, 21], which were not concor-
dant for all participants. However, 11/12 participants scored 2
or 3 on the DAFNE hypoglycaemia awareness rating and
these individuals show a fourfold increased risk of severe
hypoglycaemia [21], while 10/12 participants had a modified
Clarke score ≥4, which carries a 4.6-fold increased risk of
severe hypoglycaemia [45].
Overall, the current study supports the hypothesis that IAH
in type 1 diabetes develops as a result of habituation. This is
not firmly established as additional studies will need to be
performed to test the other features of habituation. However,
consistent with our hypothesis, we have demonstrated that the
introduction of HIT as a dishabituating stimulus, in people
with long-standing type 1 diabetes and IAH, acutely restores
a broad array of physiological, symptomatic and cognitive
responses during subsequent experimental hypoglycaemia. If
this effect is maintained following a more prolonged interven-
tion with HIT, it may offer a novel, therapeutically attractive
strategy to improve and restore hypoglycaemia awareness in
people with type 1 diabetes and reduce the risk of severe
hypoglycaemia.
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